Fcwz PTI to take up crucial issue in parliament: Mazari
LAHORE:It looks <a href=https://www.nbbalance.es>nb zapatillas</a> like Lahore鈥檚 theatre industry has been bitten by the Eid bug.In the weeks leading up to the upcoming Eidul Fitr holidays, most of the city鈥檚 most sought-after stage actresses 鈥?namely Nargis, Khusbhoo, Mahnoor, Nida Chaudhary, Zara Akbar, Megha, Shiba Rani, Sobia Khan, Raima Khan, Aafreen, 聽Huma Ali, Shanza Khan, Payal Chaudhary, Feroza and Sitara Baig 鈥撀?have been demanding more money for their work, sending theatre producer鈥檚 into a frenzy.Many of the producers have been trying to negotiate deals with former film actresses but even they have reportedly been refusing to settle for anything below Rs2.5 million. In fact, even Meera 鈥?who has never been paid m <a href=https://www.campusadidas.fr>adidas campus femme</a> ore than Rs1 million for a project previously 鈥?h <a href=https://www.stanley-cup.us>stanley website</a> as increased her demands.Celebrating Sufism and promoting the message of peaceWhat鈥檚 making things harder for the producers is the fact that many of the popular actresses have relocated and are performing in other cities such as Multan, Faisalabad, Rawalpindi and Gujr MorphoSys AG and US-based biopharmaceutical company Xencor, Inc., announced the signing of a worldwide exclusive license and collaboration agreement for an antibody in Phase 1 clinical development.The agreement provides MorphoSys with an exclusive worldwide license to XmAb5574, a high potency monoclonal antibody developed by Xencor for the treatment of B-cell malignan <a href=https://www.nike-dunk.it>nike sb dunk</a> cies.As part of the agreement, the companies will collaborate on the Phase 1 trial in patients with chronic lymphocytic leukemia (CLL) in the U.S.A., for which Xencor will continue to <a href=https://www.dunks.fr>dunk</a> carry the costs under its development plan. MorphoSys will be solely responsible for further clinical development.Xencor will receive an upfront payment of US$ 13 million (approx. 鈧?10.5 million), and will be eligible to receive development-, regulatory- and commercialization- <a href=https://www.nike-dunk.es>nike dunk low</a> related milestone payments and tiered royalties based on product sales. Further financial terms were not disclosed.XmAb5574, which will be renamed MOR208, is a humanized